Learning Objectives
- Explain how topical ingredients penetrate the skin barrier and what factors influence delivery
- Describe the mechanism of action of each key vitamin and antioxidant covered in this module
- Identify which skin types and conditions each ingredient is best suited to — and why
- Understand the stability and formulation requirements that determine product efficacy
- Confidently recommend or advise on topical actives as part of a broader treatment plan
- Recognise active combinations that are synergistic versus those that require careful timing
Section 01 — Why Topicals Matter in Aesthetic Medicine
Topical skincare is not cosmetic in the superficial sense. In aesthetic medicine, evidence-based topical therapy serves three distinct roles: it prepares skin before procedural treatments, optimises and extends outcomes after them, and provides ongoing maintenance between visits. A practitioner who understands the evidence behind topical actives is better equipped to advise patients, design treatment plans, and explain the biological rationale behind their recommendations.
The challenge is that the skincare industry produces an enormous volume of products that outpace the evidence — or that market ingredients at concentrations too low to exert a biological effect. This module focuses on ingredients that have a meaningful clinical evidence base and are commonly encountered in both professional and retail skincare contexts.
Foundation note
If you are new to skincare actives, think of them in two broad categories: correctors (actives that change something in the skin — retinoids, vitamin C, AHAs) and supporters (actives that maintain or restore the skin's own function — niacinamide, panthenol, vitamin E). Both categories are clinically valuable and often work best together.
Section 02 — Topical Penetration: What Gets In and Why
For a topical ingredient to be clinically active, it must penetrate the stratum corneum and reach its site of action. The skin's barrier function — which we explored in Module 03.02 — is precisely what makes this difficult. Understanding the basic rules of penetration explains why product formulation matters as much as ingredient selection.
The dominant pathway for most cosmetic actives is transcellular — directly through corneocytes — or intercellular — through the lipid matrix between cells. Follicular penetration is a secondary route that becomes more important for larger molecules.
Advanced — Lipinski's rules applied to skin
The four properties that govern transcellular penetration: molecular weight <500 Da (smaller penetrates more readily); lipophilicity (log P between 1–3 is optimal — too hydrophilic and the molecule is rejected by the lipid matrix; too lipophilic and it cannot partition back into the aqueous intercellular environment); low ionisation at skin surface pH; and absence of excessive hydrogen bonding. L-ascorbic acid at high pH is ionised and barely penetrates — this is why vitamin C formulations require a pH of 2.5–3.5 for optimal delivery.
Foundation note — vehicle matters
The vehicle (serum, cream, oil, gel) that carries an active ingredient significantly influences how much reaches its target. A well-formulated serum with appropriate pH and penetration enhancers will outperform a poorly formulated product with a higher ingredient concentration on the label. This is why clinician-grade or prescription formulations frequently outperform comparable retail products — not always in ingredient, but in delivery system.
Section 03 — Vitamin A: The Retinoids
Vitamin A and its derivatives — collectively called retinoids — are the most comprehensively studied topical actives in aesthetic medicine. Tretinoin (all-trans retinoic acid) remains one of the few topical ingredients with Level I evidence for reversal of photoageing. Understanding the retinoid family is fundamental to every skin consultation.
How retinoids work
Retinoids exert their effects primarily by binding to nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs) — transcription factors that regulate the expression of hundreds of genes. Key downstream effects include: stimulation of procollagen I and III synthesis; suppression of matrix metalloproteinases (MMPs) that break down collagen; normalisation of epidermal turnover (cell cycle acceleration); reduction of keratinocyte cohesion in the stratum corneum (exfoliation); and inhibition of melanogenesis.
Advanced — retinoid signalling
Only retinoic acid (tretinoin) binds directly to RARs. All other retinoid forms — retinaldehyde, retinol, retinyl esters — must be enzymatically converted by the skin to retinoic acid before they can activate gene expression. Each conversion step introduces inefficiency, which explains the potency gradient below. The retinoid irritation response (dryness, peeling, erythema) is also mediated through RAR signalling — it is not an allergy but a pharmacological effect of retinoic acid activity. It generally diminishes with continued use as the skin acclimatises.
The retinoid conversion ladder
Tretinoin (retinoic acid)
None — active form
Very high
Prescription only (AU). Gold standard for photoageing and acne. Significant irritation potential.
Adapalene
None — synthetic retinoid
High
Selective RAR-β/γ agonist. Less irritating than tretinoin. TGA-approved OTC (0.1%) for acne. Excellent anti-comedogenic.
Retinaldehyde (retinal)
1 step
Moderate–high
Strongest available OTC retinoid in most markets. Also has direct antibacterial effect. Common in professional-grade retail (0.05–0.1%).
Retinol
2 steps
Moderate
Most common OTC retinoid. Wide range of concentrations (0.025–1%+). Effective with consistent use; results take longer than tretinoin.
Retinyl esters (palmitate, acetate, propionate)
3+ steps
Low
Gentlest option. Suitable for very sensitive skin or retinoid-naive patients. Often found in mass-market products as a marketing inclusion rather than an active dose.
Bakuchiol
Not a retinoid — plant-derived
Low–moderate
Functional retinoid alternative. Activates some RAR pathways. Significantly gentler. Emerging evidence for comparable anti-ageing effects at 0.5–1%. Suitable as a true retinoid alternative in sensitive or pregnant patients.
Skin type & condition relevance — Vitamin A / Retinoids
Photoageing & fine lines: First-line topical. Strongest evidence base. Start with retinol 0.025–0.05%, increase slowly. Tretinoin 0.025–0.1% for patients under prescriber supervision.
Acne & comedonal congestion: Retinoids normalise follicular keratinisation — addressing the primary pathophysiological step in comedone formation. Adapalene is preferred for acne (less irritating, strong evidence, OTC available). Tretinoin effective for both inflammatory and non-inflammatory acne.
Post-inflammatory hyperpigmentation (PIH): Retinoids accelerate pigmented cell turnover and inhibit tyrosinase activity — supportive for PIH. However, retinoid dermatitis (barrier disruption, erythema) can trigger new PIH in darker phototypes. Introduce very slowly; combine with barrier support (panthenol, niacinamide).
Fitzpatrick IV–VI (darker skin types): Use with care. The risk is not the retinoid itself — it is the irritation response triggering PIH. Start at the lowest concentration, use every second to third night, and ensure concurrent SPF and barrier support.
Sensitive/rosacea skin: Retinyl esters or bakuchiol are preferred. True rosacea with active erythema may worsen initially with retinoids — introduce only after barrier is stabilised.
Pregnancy: All retinoids are contraindicated in pregnancy. Bakuchiol is the recommended alternative.
Clinical application — retinoid initiation protocol
The most common reason patients discontinue retinoids is the initial irritation response. A "retinoid sandwich" or buffering approach — applying moisturiser before and after the retinoid — reduces barrier disruption without significantly compromising efficacy in retinoid-naive patients. For first 2–4 weeks: apply every second to third night. Weeks 5–8: every second night. Week 9+: nightly if tolerated. Always instruct patients on strict daily broad-spectrum SPF while using retinoids — the epidermis is thinner and more UV-sensitive during active retinoid therapy.
Section 04 — Vitamin B3: Niacinamide
Niacinamide (nicotinamide) is the biologically active amide form of vitamin B3. It is water-soluble, exceptionally stable across a wide pH range, and compatible with almost every other topical active. It is one of the most versatile and evidence-backed ingredients in aesthetic skincare.
Mechanisms of action
Niacinamide works through several independent pathways simultaneously — which is what makes it so broadly applicable:
Melanosome transfer inhibition: Niacinamide does not inhibit melanin synthesis within the melanocyte. Instead, it interferes with the transfer of melanosomes (melanin-containing organelles) from melanocytes to surrounding keratinocytes. This is a distinct mechanism from most other brightening agents. Effect: reduced pigment distribution across the epidermis.
Barrier function support: Niacinamide increases synthesis of ceramides, free fatty acids, and cholesterol in the stratum corneum — the key lipids of the skin barrier. Reduces transepidermal water loss (TEWL). Effect: measurable barrier improvement within 2–4 weeks.
Sebum regulation: Inhibits sebaceous lipid excretion. Clinically significant reduction in sebum production at concentrations of 2–4%.
Anti-inflammatory: Suppresses cytokine production (TNF-α, IL-6) and reduces erythema. Key mechanism in rosacea and acne management.
Anti-glycation: Prevents non-enzymatic cross-linking of collagen by advanced glycation end-products (AGEs) — a lesser-discussed but significant ageing mechanism.
Skin type & condition relevance — Niacinamide
Uneven skin tone / hyperpigmentation: First-line adjunct. Reduces pigment distribution via melanosome transfer inhibition. Clinical improvement in solar lentigines and diffuse hyperpigmentation at 4–5% over 8–12 weeks. Safe across all phototypes.
Oily / acne-prone skin: Sebum reduction, anti-inflammatory, comedone prevention — highly suitable. Concentrations of 2–4% for sebum; 5%+ for pigmentation.
Sensitive / rosacea-prone skin: Anti-inflammatory and barrier-repairing properties make niacinamide one of the few actives appropriate for active rosacea. Unlikely to trigger flares. Typically very well tolerated.
Dry / compromised barrier: Ceramide synthesis stimulation supports barrier restoration. Excellent in post-procedure protocols.
Fitzpatrick IV–VI: One of the safest brightening options for darker skin types. No known risk of PIH, no irritation at standard concentrations (2–10%). Highly recommended as the backbone of PIH management protocols.
Advanced — the niacinamide and vitamin C compatibility question
A longstanding claim in skincare is that niacinamide and vitamin C cannot be used together because they form niacin (nicotinic acid), which causes flushing. This is based on an old in vitro study using concentrations far beyond those found in skincare. At typical use concentrations and modern formulation pH, this interaction is clinically negligible. They may be layered — or combined in a single formulation — without meaningful loss of efficacy for either ingredient. If in doubt, apply vitamin C (morning) and niacinamide (morning or evening) separately. (Levin & Momin, 2010)
Section 05 — Vitamin B5: Panthenol & Dexpanthenol
Panthenol (provitamin B5, or D-panthenol) is the alcohol analogue of pantothenic acid. It is converted in the skin to pantothenic acid, a component of coenzyme A — required for fatty acid synthesis and energy metabolism in keratinocytes. In aesthetic medicine, panthenol is primarily valued as a potent humectant, barrier-repair agent, and post-procedure recovery ingredient.
Key actions
Humectant: Panthenol attracts and retains water in the stratum corneum. Effective as a standalone hydrating agent and in combination with other humectants (hyaluronic acid, glycerin).
Barrier repair: Supports synthesis of keratinocyte lipids. Accelerates re-epithelialisation in studies of minor wound healing. Reduces TEWL.
Anti-inflammatory: Measurable reduction in erythema and itch — relevant in post-laser and post-peel contexts.
Wound healing support: Multiple studies demonstrate accelerated re-epithelialisation in superficial wounds treated with dexpanthenol. Particularly relevant following ablative resurfacing, chemical peels, or microneedling.
Skin type & condition relevance — Panthenol / Vitamin B5
Post-procedure skin: Primary use case in aesthetic medicine. Accelerates re-epithelialisation, reduces erythema, supports barrier recovery. Recommend in the first 7 days post-ablative or semi-ablative procedures as part of a simplified barrier-recovery protocol (no actives, just panthenol, a gentle cleanser, and SPF).
Dry / dehydrated skin: Excellent humectant and emollient. Suitable as a daily layer under moisturiser.
Sensitive / compromised barrier: Well tolerated, non-irritating, non-comedogenic. One of the safest ingredients across all skin types.
All phototypes: No known risks across Fitzpatrick I–VI. No photosensitivity.
Section 06 — Vitamin C: L-Ascorbic Acid & Derivatives
Vitamin C is an essential water-soluble nutrient and the most abundant antioxidant in human skin. Topical vitamin C addresses multiple ageing pathways simultaneously — making it arguably the highest-value corrective topical active available without a prescription. The challenge is stability and delivery, which has driven the development of multiple vitamin C derivatives.
Mechanisms of action
Antioxidant (free radical scavenging): L-ascorbic acid donates electrons to neutralise reactive oxygen species (ROS) generated by UV radiation, air pollution, and metabolic activity. This protects existing collagen and cell membranes from oxidative degradation.
Collagen synthesis cofactor: Ascorbic acid is an obligate cofactor for prolyl hydroxylase and lysyl hydroxylase — enzymes responsible for hydroxylating proline and lysine residues in procollagen chains. Without adequate vitamin C, collagen triple helix formation is impaired. Topically applied ascorbic acid directly supports fibroblast collagen production.
Tyrosinase inhibition: Vitamin C inhibits tyrosinase (the rate-limiting enzyme in melanin synthesis) and also reduces oxidised DOPA-quinone back to DOPA — interrupting melanin formation at two points. Clinical effect: reduction in hyperpigmentation, brightening of skin tone.
Photoprotection synergy: Vitamin C does not provide SPF protection, but significantly enhances the efficacy of sunscreen by neutralising ROS that penetrate through chemical UV filters. Combining vitamin C serum with broad-spectrum SPF provides measurably superior photoprotection compared to either alone.
Vitamin C derivatives — a comparison
| Form |
Stability |
Penetration |
Best for |
Key limitation |
| L-Ascorbic acid (LAA) |
Low — oxidises readily |
High (requires pH <3.5) |
Photoageing, pigmentation, collagen |
Irritation at high %; unstable in light/air/heat |
| Ascorbyl glucoside (AA-2G) |
High |
Moderate (enzyme-dependent) |
Sensitive skin, maintenance |
Requires skin enzyme (α-glucosidase) for conversion |
| Sodium ascorbyl phosphate (SAP) |
High |
Moderate (water-soluble) |
Acne-prone, oily skin, pigmentation |
Less potent than LAA; antimicrobial benefit against C. acnes |
| Magnesium ascorbyl phosphate (MAP) |
High |
Moderate |
Sensitive skin, dry/mature |
Lower bioavailability than LAA; good for irritation-prone patients |
| Ascorbyl tetraisopalmitate (ATIP) |
Very high |
High (oil-soluble) |
Photoageing, dry skin, mature skin |
Oil-based — not suitable for very oily or acne-prone skin |
| Ethyl ascorbic acid (3-O-ethyl ascorbic acid) |
High |
Good (amphiphilic) |
Balanced option — most skin types |
Emerging ingredient; less long-term clinical data than LAA |
Skin type & condition relevance — Vitamin C
Photoageing / photodamage: First-line — combines antioxidant protection, collagen stimulation, and pigmentation correction in one step. Use L-ascorbic acid 10–20% in the morning under SPF for best effect.
Hyperpigmentation / melasma: Tyrosinase inhibition and melanin reduction — effective adjunct. Combine with niacinamide (melanosome transfer) and SPF for a multi-pathway depigmentation approach.
Oily / acne-prone skin: Sodium ascorbyl phosphate (SAP) is preferred — stable, water-soluble, and has anti-P. acnes antimicrobial activity. Avoid oil-based vitamin C derivatives.
Sensitive / rosacea-prone skin: LAA at 10–15% can initially cause stinging due to low pH. Consider ascorbyl glucoside, MAP, or ethyl ascorbic acid — effective and gentler formulations.
Fitzpatrick IV–VI: Vitamin C is an excellent and safe brightening option for darker skin types — no PIH risk from the ingredient itself. The low-pH formulations (LAA) may cause transient stinging; consider derivatives if this is an issue.
Advanced — the C + E + Ferulic acid combination
The combination of 15% L-ascorbic acid, 1% alpha-tocopherol (vitamin E), and 0.5% ferulic acid has been shown in controlled studies to produce an eightfold increase in photoprotection compared to no antioxidant, and to significantly outperform each ingredient applied alone. Ferulic acid doubles the antioxidant potency of vitamins C and E by a photo-stabilisation mechanism. This specific combination is the most evidence-supported antioxidant regimen available. (Pinnell et al., 2001; Lin et al., 2003)
Section 07 — Vitamin E: Tocopherol
Vitamin E is the collective name for a group of eight fat-soluble compounds: four tocopherols (alpha, beta, gamma, delta) and four tocotrienols. Alpha-tocopherol is the most biologically active form and the most common in skincare formulations. It is a lipid-soluble antioxidant — the primary antioxidant defence within cell membranes.
Key actions
Lipid-phase antioxidant: Alpha-tocopherol neutralises peroxyl radicals within phospholipid membranes — protecting cell membranes and mitochondria from oxidative damage that water-soluble antioxidants (like vitamin C) cannot reach.
Anti-inflammatory: Inhibits arachidonic acid metabolism, reducing prostaglandin and leukotriene production. Reduces post-UV erythema.
Emollient and skin feel: Tocopherol acetate and tocopheryl acetate are commonly used for their emollient properties and skin feel — providing texture in formulations rather than significant antioxidant activity (the acetate ester must be cleaved by skin enzymes to release active tocopherol).
Synergy with vitamin C: After vitamin E donates an electron to quench a free radical, it becomes a tocopheroxyl radical (oxidised and inactive). Vitamin C regenerates vitamin E by reducing the tocopheroxyl radical back to active tocopherol. This electron recycling makes C + E synergistic rather than simply additive.
Skin type & condition relevance — Vitamin E
All skin types — photoprotection: Best used in combination with vitamin C (morning routine) as part of an antioxidant serum — the C + E pairing provides broader free radical defence than either alone.
Dry / mature skin: Tocopherol has emollient properties and supports lipid barrier integrity. Beneficial in cream or oil formulations for dry or mature skin types.
Post-procedure / scar prevention: Commonly included in post-procedural scar prevention protocols. However, the evidence for topical vitamin E in scar reduction specifically is inconsistent — some studies show benefit; others do not. Its role is more reliably established as an antioxidant than as a scar modifier.
Acne-prone: Some individuals with acne-prone skin react to tocopherol formulations — particularly heavy oil-based preparations. Patch test and use in lightweight formulations.
Section 08 — Key Antioxidants Beyond Vitamins
Beyond vitamins C and E, a number of plant-derived and synthetic antioxidants have accumulated meaningful evidence for topical use in aesthetic medicine. These are frequently included in professional skincare formulations as supporting or synergistic actives.
Ferulic acid
A hydroxycinnamic acid derived from the cell walls of plants (rice bran, oats, wheat). Ferulic acid is a powerful phenolic antioxidant that, when combined with vitamins C and E, doubles their antioxidant potency through photostabilisation. It is rarely used as a standalone active — its primary role is as a synergistic potentiator in antioxidant serums.
Skin type & condition relevance — Ferulic acid
Universal use as part of a C + E + ferulic morning antioxidant serum. Particularly valuable in photoaged skin and high UV-exposure climates. No significant skin type restrictions. Adds potency to vitamin C without requiring a higher (more irritating) vitamin C concentration — beneficial in sensitive skin where LAA at 20% would be too irritating.
Resveratrol
A stilbene polyphenol found in grape skin, red wine, and Japanese knotweed. Resveratrol activates sirtuins (particularly SIRT1) — NAD+-dependent deacetylases involved in cellular stress response and longevity pathways. Topically, it provides antioxidant protection, mild anti-inflammatory activity, and emerging evidence for collagen stimulation. Penetration in simple formulations is poor — bioavailability-enhanced delivery systems (encapsulation, liposomes) improve efficacy.
Skin type & condition relevance — Resveratrol
Best suited as an evening antioxidant — complements the morning C + E + ferulic approach. Particularly relevant for photoaged skin and mature skin types. Well tolerated — suitable for sensitive skin in stabilised formulations.
Bakuchiol
A meroterpene phenol derived from the seeds of Psoralea corylifolia (babchi plant). Bakuchiol is described as a "functional retinoid" — it activates RAR-α and RAR-β pathways and upregulates genes involved in collagen synthesis, similarly to retinol. A 2018 double-blind RCT (Dhaliwal et al.) comparing 0.5% bakuchiol twice daily with 0.5% retinol once daily found comparable improvement in photoageing parameters with significantly less irritation in the bakuchiol group.
Skin type & condition relevance — Bakuchiol
Primary indication: True retinoid alternative for patients who cannot tolerate retinoids or for whom retinoids are contraindicated (pregnancy, active rosacea, very sensitive/compromised barrier skin).
Fitzpatrick IV–VI: Excellent option — the lack of retinoid-associated barrier disruption removes the PIH risk inherent in retinoid initiation in darker skin types.
All ageing skin types: Can be used morning and/or evening — no photosensitivity associated. Can be combined with retinol for an additive anti-ageing effect.
Coenzyme Q10 (Ubiquinone)
CoQ10 is an endogenous molecule in the mitochondrial electron transport chain. Skin CoQ10 levels decline with age and UV exposure. Topically, CoQ10 has antioxidant and cellular energy-support roles. It has demonstrated reduction in UV-induced oxidative stress in skin models and some clinical evidence for improvement in fine lines. Penetration is limited by its relatively large molecular size — formulation quality significantly influences efficacy.
Skin type & condition relevance — CoQ10
Primarily relevant for mature, photoaged skin where mitochondrial function and cellular energy metabolism are declining. Often included as a supporting antioxidant in premium anti-ageing formulations. Well tolerated across all skin types.
Section 09 — Combining Actives: Synergies and Conflicts
The full potential of topical actives is often realised through thoughtful combination — but not all pairings are beneficial, and some require timing separation to avoid interference or excessive irritation.
Well-established synergies
- Vitamin C (LAA) + Vitamin E + Ferulic acid — morning antioxidant stack
- Retinoid + Niacinamide — retinoid tolerance support; niacinamide counteracts barrier disruption
- Retinoid + Bakuchiol — additive anti-ageing effect; bakuchiol may buffer retinoid irritation
- Niacinamide + AHA — niacinamide buffers post-AHA barrier disruption
- Panthenol + any active — universal barrier support; accelerates recovery
- Vitamin C (morning) + Retinoid (evening) — complementary timing; no direct interaction
- Azelaic acid + Niacinamide — dual pigmentation pathway coverage, synergistic in melasma
Combinations requiring care or spacing
- High-% LAA + Retinoid — both at low pH or causing barrier disruption; separate AM/PM
- Retinoid + Direct acids (AHA/BHA) — excessive irritation if used simultaneously; separate AM/PM or use on alternate nights
- Benzoyl peroxide + Retinoid — BP oxidises retinol; separate AM/PM
- Multiple exfoliating acids simultaneously — over-exfoliation; pick one or use combination products with lower concentrations
- Vitamin C + Low pH acids (AHA) in the same step — not harmful but vitamin C requires <3.5 pH; layering immediately after AHA is fine, not before
Foundation note — AM / PM framework
When advising patients on a routine, a simple AM/PM framework resolves most compatibility questions. Morning: vitamin C serum → moisturiser → SPF. Evening: cleanse → retinoid (or acid, not both on the same night initially) → barrier support (niacinamide, panthenol, moisturiser). This structure is evidence-based, practical, and avoids the most common combination errors.
Section 10 — Quick Reference: Ingredient × Condition Matrix
The table below provides a rapid reference guide to ingredient selection by primary skin condition. Ratings reflect typical suitability at standard use concentrations in well-formulated products.
| Ingredient |
Photoageing / fine lines |
Acne / oily |
Hyperpigmentation / PIH |
Sensitive / rosacea |
Fitzpatrick IV–VI |
Post-procedure |
| Tretinoin (Rx) |
✓✓✓ |
✓✓✓ |
✓ (caution) |
✗ |
Low & slow |
Phase 3 only |
| Retinol (OTC) |
✓✓ |
✓✓ |
✓ (caution) |
Low dose only |
Low & slow |
Phase 3 only |
| Bakuchiol |
✓✓ |
✓ |
✓ |
✓✓✓ |
✓✓✓ |
Phase 2–3 |
| Niacinamide |
✓ |
✓✓✓ |
✓✓✓ |
✓✓✓ |
✓✓✓ |
✓✓✓ |
| Vitamin C (LAA) |
✓✓✓ |
SAP preferred |
✓✓✓ |
Derivative preferred |
✓✓ |
Phase 2–3 |
| Vitamin E |
✓✓ |
Lightweight only |
✓ |
✓✓ |
✓✓ |
✓✓ |
| Panthenol |
✓ |
✓✓ |
✓ |
✓✓✓ |
✓✓✓ |
✓✓✓ |
| Ferulic acid |
✓✓✓ |
✓✓ |
✓✓ |
✓ (in combo) |
✓✓✓ |
Phase 2–3 |
| Resveratrol |
✓✓ |
✓ |
✓ |
✓✓ |
✓✓ |
Phase 2–3 |
✓✓✓ = strong match / first-line · ✓✓ = good match · ✓ = suitable / adjunct · Caution = conditional use · ✗ = generally contraindicated · Post-procedure phases: 1 = re-epithelialisation (days 1–7); 2 = proliferation (days 4–21); 3 = remodelling (week 3+)
Reference Index
All statements regarding mechanisms, clinical evidence, and concentrations in this module are drawn from or consistent with the following peer-reviewed sources. References are maintained and updated on each review cycle.
- Kang S, Voorhees JJ. Photoaging therapy with topical tretinoin: an evidence-based analysis. J Am Acad Dermatol. 1998;39(2 Pt 3):S55–S61. [Retinoid evidence base for photoageing]
- Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379(6563):335–339. [MMP pathway; retinoid mechanism]
- Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836–859. [Original tretinoin photoageing paper]
- Mukherjee S, Date A, Patravale V, Korting HC, Roeder A, Weindl G. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327–348. [Retinoid forms review]
- Dhaliwal S, Rybak I, Ellis SR, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. Br J Dermatol. 2019;180(2):289–296. [Bakuchiol vs. retinol RCT]
- Bissett DL, Oblong JE, Berge CA. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31(7 Pt 2):860–865. [Niacinamide clinical trial]
- Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20–31. [Niacinamide melanosome transfer mechanism]
- Gehring W. Nicotinic acid/niacinamide and the skin. J Cosmet Dermatol. 2004;3(2):88–93. [Niacinamide barrier, sebum, anti-inflammatory review]
- Ebner F, Heller A, Rippke F, Tausch I. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002;3(6):427–433. [Panthenol/dexpanthenol clinical review]
- Pinnell SR, Yang H, Omar M, et al. Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg. 2001;27(2):137–142. [Vitamin C formulation and penetration — Pinnell]
- Lin FH, Lin JY, Gupta RD, et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol. 2005;125(4):826–832. [C + E + ferulic acid photoprotection study]
- Levin J, Momin SB. How much do we really know about our favorite cosmeceutical ingredients? J Clin Aesthet Dermatol. 2010;3(2):22–41. [Niacinamide + vitamin C compatibility review]
- Fitzpatrick RE, Rostan EF. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg. 2002;28(3):231–236. [Topical vitamin C RCT]
- Burke KE. Interaction of vitamins C and E as better cosmeceuticals. Dermatol Ther. 2007;20(5):314–321. [Vitamin C + E synergy]
- Baumann L. Cosmeceuticals and cosmetic ingredients. McGraw-Hill Education; 2015. Chapters 6–11. [Comprehensive cosmeceutical reference]
- Pandel R, Poljšak B, Godic A, Dahmane R. Skin photoaging and the role of antioxidants in its prevention. ISRN Dermatol. 2013;2013:930164. [Antioxidant review — ferulic, resveratrol, CoQ10]
- Boo YC. Human skin cells at the crossroads of UV radiation, oxidative stress, inflammation and aging: a comprehensive review. Antioxidants. 2022;11(7):1404.